AI & Machine Learning

Nov 3, 2026

Isomorphic Labs Uses AI to Enhance Drug Discovery Processes

Nov 3, 2026

AI Summary

Max Jaderberg, President of Isomorphic Labs, highlighted the role of artificial intelligence in speeding up scientific discovery and innovating drug development methods during a discussion at the 2026 Bloomberg Tech event in London.

Max Jaderberg is the President of Isomorphic Labs.
He spoke about the impact of AI on scientific discovery and drug development.
The discussion took place at the 2026 Bloomberg Tech event in London.
AI is being utilized to create new approaches in the drug discovery process.

drug discoveryisomorphic labsscientific discoveryai in healthcareinnovation

Related Stories

AI & Machine Learning

Insights on AI Implementation from JioStar's Chief Architect for 500 Million Users

19h ago

AI & Machine Learning

Grand Theft Auto VI Marks a Turning Point in Video Game Development Before AI Changes the Landscape

1d ago

AI & Machine Learning

AI's Emerging Role in Corporate Boardrooms Raises Questions About Its Future Use

1d ago

AI & Machine Learning

Addressing AI Guidance in Education Through Partnerships and Research

1d ago